Germany’s Bayer to buy US gene therapy specialist AskBio

BERLIN (AP) – German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billion.

Read more…

Please follow and like us: